21 C.F.R. § 211.22

Responsibilities of quality control unit

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

(a) There shall be a quality control unit that shall have the responsibility and authority to approve or reject all components, drug product containers, closures, in-process materials, packaging material, labeling, and drug products, and the authority to review production records to assure that no errors have occurred or, if errors have occurred, that they have been fully investigated. The quality control unit shall be responsible for approving or rejecting drug products manufactured, processed, packed, or held under contract by another company.

(b) Adequate laboratory facilities for the testing and approval (or rejection) of components, drug product containers, closures, packaging materials, in-process materials, and drug products shall be available to the quality control unit.

(c) The quality control unit shall have the responsibility for approving or rejecting all procedures or specifications impacting on the identity, strength, quality, and purity of the drug product.

(d) The responsibilities and procedures applicable to the quality control unit shall be in writing; such written procedures shall be followed.

Notes of Decisions

Cited in 6 cases (1 in the last 5 years), 1984–2025 · leading case: In Re: Ocular Therapeutix Inc v.

Sort: Relevance Newest Treatment

In Re: Ocular Therapeutix Inc v. (2020) ca1 “…been found in manufactured drug product." See 21 C.F.R. § 211.22 (a). Further, "[p]articulate matter has been noted in 10/23 lots . . . manufactured from [February 2016] to [May 4, 2017]." As plaintiffs alleged, Ocular had determin”

Crocker v. KV PHARMACEUTICAL CO. (2010) moed “Failure to follow the responsibilities and procedures applicable to the quality control unit, as required by 21 C.F.R. § 211.22 (d); b.”

National Ass'n of Pharmaceutical Manufacturers v. Department of Health & Human Services (1984) nysd “Quality Control Unit Many of the regulations challenged by plaintiffs relate to the duties to be performed by the quality control unit which each manufacturer must establish pursuant to 21 C.F.R. § 211.22 . Plaintiffs challenge virtually every regulation governing the…”

Public Pension Fund Group v. Kv Pharmaceutical Co. (2010) moed “Failure to follow the responsibilities and procedures applicable to the quality control unit, as required by 21 C.F.R. § 211.22 (d); B.”

Akorn, Inc. v. Fresenius Kabi AG (2018) delch “38 JX 112 at 9–10 (citing 21 C.F.R. §§ 211.22 (a), 211.”

Pfizer Inc. and Tris Pharma, Inc. v. the State of Texas and Tarik Ahmed (2025) texapp “…21 CFR § 211.100 . 16 21 CFR § 211.22 (a). 17 See id. PLAINTIFFS’ SECOND AMENDED PETITION PAGE 7 approved by the quality co”

Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.